Leukemia Clinical Trials in Nashville

Showing 1681-1700 of 1,768 trials

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

NCT00706862

The purpose of the study is to determine whether the combination of talactoferrin, carboplatin and paclitaxel improves progression free survival and overall survival in patients with non-small cell lung cancer compared to the combination of paclitaxel and carboplatin alone

Non Small Cell Lung Cancer

Agennix1,100 participantsStarted Feb 2009

Duarte, California, United States • Chicago, Illinois, United States • The Bronx, New York, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

NCT00034957

The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)

Carcinoma, Non-Small-Cell LungLung Neoplasms

Pfizer

Berkeley, California, United States • Greenbrae, California, United States • Los Angeles, California, United States +9 more locations

TERMINATEDPhase 3< 1 mile

Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)

NCT00124748

This study investigated the safety and efficacy of 400mg Versus 800mg imatinib in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase (CML-CP) using molecular endpoints.

Leukemia, Myeloid, Chronic Phase

Novartis Pharmaceuticals476 participantsStarted Jun 2005

Mobile, Alabama, United States • Berkeley, California, United States • Berkeley, California, United States +72 more locations

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)

Leukemia Trials in Other Cities

Use of the MiCK Assay for Apoptosis in AML

Aerobic and Strengthening Exercise for Acute Leukemia

Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer

Study of XL281 in Adults With Solid Tumors

A Comparison of Skin Prick Tests, Clinical Symptoms, and Nasal Challenge Using a New Mouse Extract

TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Trial of STAHIST in Seasonal Allergic Rhinitis

Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma

Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Other Conditions in Nashville